MedPath

Study on the clinical effect of Ganwei Tongzhi TCM Compound in preventing Barrett's esophageal canceratio

Phase 1
Recruiting
Conditions
Barrett Esophagus
Registration Number
ITMCTR2000003993
Lead Sponsor
Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients 18 years old <= age <= 70 years old, regardless of gender;
2. Patients who meet the diagnostic criteria of be;
3. Patients who understand and agree to participate in the study and sign the informed consent form.

Exclusion Criteria

1. Patients with liver and kidney damage, severe anemia and malignant tumor;
2. Patients who are allergic to the drugs used in this study;
3. Pregnant or lactating women;
4. Patients with mental illness and other patients who are unable to self describe symptoms and understand disorders.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.